These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
266 related articles for article (PubMed ID: 17260960)
1. Interfacial and lipid transfer properties of human phospholipid transfer protein: implications for the transfer mechanism of phospholipids. Setälä NL; Holopainen JM; Metso J; Wiedmer SK; Yohannes G; Kinnunen PK; Ehnholm C; Jauhiainen M Biochemistry; 2007 Feb; 46(5):1312-9. PubMed ID: 17260960 [TBL] [Abstract][Full Text] [Related]
2. Determination of human plasma phospholipid transfer protein mass and activity. Jauhiainen M; Ehnholm C Methods; 2005 Jun; 36(2):97-101. PubMed ID: 15893933 [TBL] [Abstract][Full Text] [Related]
3. Molecular and macromolecular specificity of human plasma phospholipid transfer protein. Rao R; Albers JJ; Wolfbauer G; Pownall HJ Biochemistry; 1997 Mar; 36(12):3645-53. PubMed ID: 9132017 [TBL] [Abstract][Full Text] [Related]
4. Cholesterol efflux from macrophage foam cells is enhanced by active phospholipid transfer protein through generation of two types of acceptor particles. Vikstedt R; Metso J; Hakala J; Olkkonen VM; Ehnholm C; Jauhiainen M Biochemistry; 2007 Oct; 46(42):11979-86. PubMed ID: 17900150 [TBL] [Abstract][Full Text] [Related]
5. Remodeling of HDL by phospholipid transfer protein: demonstration of particle fusion by 1H NMR spectroscopy. Korhonen A; Jauhiainen M; Ehnholm C; Kovanen PT; Ala-Korpela M Biochem Biophys Res Commun; 1998 Aug; 249(3):910-6. PubMed ID: 9731235 [TBL] [Abstract][Full Text] [Related]
6. Plasma phospholipid transfer protein activity, a determinant of HDL kinetics in vivo. Ooi EM; Watts GF; Ji J; Rye KA; Johnson AG; Chan DC; Barrett PH Clin Endocrinol (Oxf); 2006 Dec; 65(6):752-9. PubMed ID: 17121526 [TBL] [Abstract][Full Text] [Related]
7. Phospholipid transfer protein is present in human tear fluid. Jauhiainen M; Setälä NL; Ehnholm C; Metso J; Tervo TM; Eriksson O; Holopainen JM Biochemistry; 2005 Jun; 44(22):8111-6. PubMed ID: 15924430 [TBL] [Abstract][Full Text] [Related]
8. Structural basis of the lipid transfer mechanism of phospholipid transfer protein (PLTP). Zhang M; Zhai X; Li J; Albers JJ; Vuletic S; Ren G Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):1082-1094. PubMed ID: 29883800 [TBL] [Abstract][Full Text] [Related]
9. Acyl chain and headgroup specificity of human plasma phospholipid transfer protein. Huuskonen J; Olkkonen VM; Jauhiainen M; Metso J; Somerharju P; Ehnholm C Biochim Biophys Acta; 1996 Oct; 1303(3):207-14. PubMed ID: 8908155 [TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E activates the low-activity form of human phospholipid transfer protein. Jänis MT; Metso J; Lankinen H; Strandin T; Olkkonen VM; Rye KA; Jauhiainen M; Ehnholm C Biochem Biophys Res Commun; 2005 May; 331(1):333-40. PubMed ID: 15845396 [TBL] [Abstract][Full Text] [Related]
11. The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion. Lusa S; Jauhiainen M; Metso J; Somerharju P; Ehnholm C Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):275-82. PubMed ID: 8546695 [TBL] [Abstract][Full Text] [Related]
12. Structural and functional determinants of human plasma phospholipid transfer protein activity as revealed by site-directed mutagenesis of charged amino acids. Ponsin G; Qu SJ; Fan HZ; Pownall HJ Biochemistry; 2003 Apr; 42(15):4444-51. PubMed ID: 12693940 [TBL] [Abstract][Full Text] [Related]
13. Oxidative modification of HDL3 in vitro and its effect on PLTP-mediated phospholipid transfer. Huuskonen J; Olkkonen VM; Jauhiainen M; Sareneva T; Somerharju P; Ehnholm C Biochim Biophys Acta; 1998 Mar; 1391(2):181-92. PubMed ID: 9555005 [TBL] [Abstract][Full Text] [Related]
14. Phospholipid transfer protein in hemodialysis patients. Schlitt A; Heine GH; Jiang XC; Messow M; Blankenberg S; Rupprecht HJ; Ulrich C; Buerke M; Werdan K; Lackner KJ; Köhler H; Girndt M Am J Nephrol; 2007; 27(2):138-43. PubMed ID: 17308375 [TBL] [Abstract][Full Text] [Related]
15. Plasma phospholipid transfer protein. Adenovirus-mediated overexpression in mice leads to decreased plasma high density lipoprotein (HDL) and enhanced hepatic uptake of phospholipids and cholesteryl esters from HDL. Föger B; Santamarina-Fojo S; Shamburek RD; Parrot CL; Talley GD; Brewer HB J Biol Chem; 1997 Oct; 272(43):27393-400. PubMed ID: 9341191 [TBL] [Abstract][Full Text] [Related]
16. Remodeling of apolipoprotein E-containing spherical reconstituted high density lipoproteins by phospholipid transfer protein. Settasatian N; Barter PJ; Rye KA J Lipid Res; 2008 Jan; 49(1):115-26. PubMed ID: 17921435 [TBL] [Abstract][Full Text] [Related]
17. Phospholipid transfer is a prerequisite for PLTP-mediated HDL conversion. Huuskonen J; Olkkonen VM; Ehnholm C; Metso J; Julkunen I; Jauhiainen M Biochemistry; 2000 Dec; 39(51):16092-8. PubMed ID: 11123937 [TBL] [Abstract][Full Text] [Related]
18. Human plasma phospholipid transfer protein causes high density lipoprotein conversion. Jauhiainen M; Metso J; Pahlman R; Blomqvist S; van Tol A; Ehnholm C J Biol Chem; 1993 Feb; 268(6):4032-6. PubMed ID: 8440695 [TBL] [Abstract][Full Text] [Related]
19. Plasma apolipoprotein E concentration is an important determinant of phospholipid transfer protein activity in type 2 diabetes mellitus. Tan KC; Shiu SW; Wong Y; Wong WK; Tam S Diabetes Metab Res Rev; 2006; 22(4):307-12. PubMed ID: 16389649 [TBL] [Abstract][Full Text] [Related]
20. Reverse modulation of the HDL anionic peptide factor and phospholipid transfer protein activity in coronary artery disease and type 2 diabetes mellitus. Attia N; Domingo N; Lorec AM; Nakbi A; Hammami S; Ben Hamda K; Portugal H; Lairon D; Hammami M; Chanussot F Clin Biochem; 2009 Jun; 42(9):845-51. PubMed ID: 19135989 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]